These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
519 related articles for article (PubMed ID: 9703873)
1. Amplification of the CDK4 gene in sarcomas: tumor specificity and relationship with the RB gene mutation. Kanoe H; Nakayama T; Murakami H; Hosaka T; Yamamoto H; Nakashima Y; Tsuboyama T; Nakamura T; Sasaki MS; Toguchida J Anticancer Res; 1998; 18(4A):2317-21. PubMed ID: 9703873 [TBL] [Abstract][Full Text] [Related]
2. MDM2 gene amplification in bone and soft-tissue tumors: association with tumor progression in differentiated adipose-tissue tumors. Nakayama T; Toguchida J; Wadayama B; Kanoe H; Kotoura Y; Sasaki MS Int J Cancer; 1995 Oct; 64(5):342-6. PubMed ID: 7591308 [TBL] [Abstract][Full Text] [Related]
3. Coordinated expression and amplification of the MDM2, CDK4, and HMGI-C genes in atypical lipomatous tumours. Dei Tos AP; Doglioni C; Piccinin S; Sciot R; Furlanetto A; Boiocchi M; Dal Cin P; Maestro R; Fletcher CD; Tallini G J Pathol; 2000 Apr; 190(5):531-6. PubMed ID: 10727978 [TBL] [Abstract][Full Text] [Related]
5. Analysis of 12q13-15 genes in parosteal osteosarcoma. Gamberi G; Ragazzini P; Benassi MS; Ferrari C; Sollazzo MR; Molendini L; Merli M; Magagnoli G; Ruggieri P; Balladelli A; Orlando C; Bacchini P; Pazzagli M; Picci P Clin Orthop Relat Res; 2000 Aug; (377):195-204. PubMed ID: 10943202 [TBL] [Abstract][Full Text] [Related]
6. Refined mapping of 12q13-q15 amplicons in human malignant gliomas suggests CDK4/SAS and MDM2 as independent amplification targets. Reifenberger G; Ichimura K; Reifenberger J; Elkahloun AG; Meltzer PS; Collins VP Cancer Res; 1996 Nov; 56(22):5141-5. PubMed ID: 8912848 [TBL] [Abstract][Full Text] [Related]
7. Separate amplified regions encompassing CDK4 and MDM2 in human sarcomas. Berner JM; Forus A; Elkahloun A; Meltzer PS; Fodstad O; Myklebost O Genes Chromosomes Cancer; 1996 Dec; 17(4):254-9. PubMed ID: 8946207 [TBL] [Abstract][Full Text] [Related]
8. Co-amplification and overexpression of CDK4, SAS and MDM2 occurs frequently in human parosteal osteosarcomas. Wunder JS; Eppert K; Burrow SR; Gokgoz N; Bell RS; Andrulis IL Oncogene; 1999 Jan; 18(3):783-8. PubMed ID: 9989829 [TBL] [Abstract][Full Text] [Related]
9. Amplification and protein expression of chromosome 12q13-15 genes in osteosarcomas of the jaws. Lopes MA; Nikitakis NG; Ord RA; Sauk J Oral Oncol; 2001 Oct; 37(7):566-71. PubMed ID: 11564577 [TBL] [Abstract][Full Text] [Related]
11. Amplification of CDK4, MDM2, SAS and GLI genes in leiomyosarcoma, alveolar and embryonal rhabdomyosarcoma. Ragazzini P; Gamberi G; Pazzaglia L; Serra M; Magagnoli G; Ponticelli F; Ferrari C; Ghinelli C; Alberghini M; Bertoni F; Picci P; Benassi MS Histol Histopathol; 2004 Apr; 19(2):401-11. PubMed ID: 15024701 [TBL] [Abstract][Full Text] [Related]
12. Characterization of the 12q13-15 amplicon in soft tissue tumors. Nilbert M; Rydholm A; Mitelman F; Meltzer PS; Mandahl N Cancer Genet Cytogenet; 1995 Aug; 83(1):32-6. PubMed ID: 7656201 [TBL] [Abstract][Full Text] [Related]
13. p53 Mutation and MDM2 amplification in human soft tissue sarcomas. Leach FS; Tokino T; Meltzer P; Burrell M; Oliner JD; Smith S; Hill DE; Sidransky D; Kinzler KW; Vogelstein B Cancer Res; 1993 May; 53(10 Suppl):2231-4. PubMed ID: 8387391 [TBL] [Abstract][Full Text] [Related]
14. Most malignant fibrous histiocytomas developed in the retroperitoneum are dedifferentiated liposarcomas: a review of 25 cases initially diagnosed as malignant fibrous histiocytoma. Coindre JM; Mariani O; Chibon F; Mairal A; De Saint Aubain Somerhausen N; Favre-Guillevin E; Bui NB; Stoeckle E; Hostein I; Aurias A Mod Pathol; 2003 Mar; 16(3):256-62. PubMed ID: 12640106 [TBL] [Abstract][Full Text] [Related]
15. Molecular analysis of p53, MDM2, and H-ras genes in osteosarcoma and malignant fibrous histiocytoma of bone in patients older than 40 years. Kawaguchi K; Oda Y; Sakamoto A; Saito T; Tamiya S; Iwamoto Y; Tsuneyoshi M Mod Pathol; 2002 Aug; 15(8):878-88. PubMed ID: 12181274 [TBL] [Abstract][Full Text] [Related]
16. Analysis of SAS gene and CDK4 and MDM2 proteins in low-grade osteosarcoma. Ragazzini P; Gamberi G; Benassi MS; Orlando C; Sestini R; Ferrari C; Molendini L; Sollazzo MR; Merli M; Magagnoli G; Bertoni F; Bohling T; Pazzagli M; Picci P Cancer Detect Prev; 1999; 23(2):129-36. PubMed ID: 10101594 [TBL] [Abstract][Full Text] [Related]
17. CDK4 gene amplification in osteosarcoma: reciprocal relationship with INK4A gene alterations and mapping of 12q13 amplicons. Wei G; Lonardo F; Ueda T; Kim T; Huvos AG; Healey JH; Ladanyi M Int J Cancer; 1999 Jan; 80(2):199-204. PubMed ID: 9935200 [TBL] [Abstract][Full Text] [Related]
18. MDM2 and CDK4 immunohistochemistry is a valuable tool in the differential diagnosis of low-grade osteosarcomas and other primary fibro-osseous lesions of the bone. Dujardin F; Binh MB; Bouvier C; Gomez-Brouchet A; Larousserie F; Muret Ad; Louis-Brennetot C; Aurias A; Coindre JM; Guillou L; Pedeutour F; Duval H; Collin C; de Pinieux G Mod Pathol; 2011 May; 24(5):624-37. PubMed ID: 21336260 [TBL] [Abstract][Full Text] [Related]
19. Characterization of the 12q amplicons in lipomatous soft tissue tumors by multiplex ligation-dependent probe amplification-based copy number analysis. Creytens D; Van Gorp J; Speel EJ; Ferdinande L Anticancer Res; 2015 Apr; 35(4):1835-42. PubMed ID: 25862836 [TBL] [Abstract][Full Text] [Related]
20. Characterization of the 12q15 MDM2 and 12q13-14 CDK4 amplicons and clinical correlations in osteosarcoma. Mejia-Guerrero S; Quejada M; Gokgoz N; Gill M; Parkes RK; Wunder JS; Andrulis IL Genes Chromosomes Cancer; 2010 Jun; 49(6):518-25. PubMed ID: 20196171 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]